EDGAR Filing Documents for 0001628280-21-005139

Form 8-K - Current report:

SEC Accession No. 0001628280-21-005139

Filing Date

2021-03-19

Accepted

2021-03-19 09:05:44

Documents

Period of Report

2021-03-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	xfor-20210318.htm iXBRL	8-K	60854
2	EX-4.1	formofprefundedwarrant.htm	EX-4.1	114743
3	EX-10.1	securitiespurchaseagreement.htm	EX-10.1	308468
4	EX-10.2	regrights.htm	EX-10.2	234494
5	EX-10.3	abingworthoptionagreementf.htm	EX-10.3	30970
6	EX-99.1	pressrelease.htm	EX-99.1	11928
	Complete submission text file	0001628280-21-005139.txt		1030597

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	xfor-20210318.xsd	EX-101.SCH	2423
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	xfor-20210318_cal.xml	EX-101.CAL	710
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	xfor-20210318_def.xml	EX-101.DEF	1643
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	xfor-20210318_lab.xml	EX-101.LAB	25998
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	xfor-20210318_pre.xml	EX-101.PRE	13731
12	EXTRACTED XBRL INSTANCE DOCUMENT	xfor-20210318_htm.xml	XML	11812

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134

Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300

X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)